secwatch.observer — SEC 8-K summary
======================================

Issuer:     LeonaBio, Inc. (LONA)
CIK:        0001620463
Form:       8-K
Filed at:   2022-01-31T23:59:59+00:00
Accession:  0001193125-22-023358
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Athira appoints Grant Pickering director; CEO gets $543k salary, 50% bonus target, enhanced severance
--------------------------------------------------------------------------------

- Grant Pickering (CEO of Vaxcyte) appointed to board effective Jan 27, 2022.
- CEO Mark Litton salary raised from $510k to $543,400; bonus target increased from 40% to 50%.
- Amended severance: 12 months base salary (non-CIC) or 18 months salary + 150% bonus (CIC), plus equity acceleration.
- Director compensation policy amended: $35k/year cash retainer; initial option grant 27,742 shares vesting monthly over 3 years; annual option grant 13,871 shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1620463/000119312522023358/0001193125-22-023358-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1620463/000119312522023358/d290928d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-023358

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer